Acurx Pharmaceuticals (ACXP) Tops Q1 EPS by 27c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.11), $0.27 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight
• Sodexo (SW:FP) (SDXAY) PT Raised to EUR53 at Deutsche Bank